H

Humedix Co Ltd
KOSDAQ:200670

Watchlist Manager
Humedix Co Ltd
KOSDAQ:200670
Watchlist
Price: 41 100 KRW 1.11% Market Closed
Market Cap: 461.6B KRW

Relative Value

The Relative Value of one Humedix Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 41 100 KRW, Humedix Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Humedix Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
41
vs Industry
43
Median 3Y
2.7
Median 5Y
2.4
Industry
2.7
Forward
2.4
vs History
95
vs Industry
33
Median 3Y
12
Median 5Y
12.7
Industry
21.6
Forward
9.2
vs History
55
vs Industry
45
Median 3Y
8.9
Median 5Y
10.1
Industry
16.9
vs History
47
vs Industry
31
Median 3Y
11.8
Median 5Y
10.8
Industry
22.9
vs History
57
vs Industry
38
Median 3Y
1.8
Median 5Y
1.7
Industry
2.3
vs History
47
vs Industry
49
Median 3Y
2
Median 5Y
1.8
Industry
3
Forward
1.7
vs History
61
vs Industry
43
Median 3Y
4.4
Median 5Y
4.4
Industry
5.6
vs History
66
vs Industry
43
Median 3Y
5.9
Median 5Y
6.1
Industry
13.4
Forward
5.3
vs History
69
vs Industry
40
Median 3Y
7.6
Median 5Y
9.3
Industry
16.7
Forward
6.6
vs History
66
vs Industry
48
Median 3Y
6.5
Median 5Y
7.8
Industry
16.1
vs History
63
vs Industry
35
Median 3Y
8.1
Median 5Y
9.7
Industry
18.9
vs History
20
vs Industry
31
Median 3Y
2.1
Median 5Y
1.8
Industry
2

Multiples Across Competitors

Competitors Multiples
Humedix Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Humedix Co Ltd
KOSDAQ:200670
425.8B KRW 2.6 7.7 5.3 6.7
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 109 159.5
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.4 10.2 12.1
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
KR
H
Humedix Co Ltd
KOSDAQ:200670
Average P/E: 23
7.7
15%
0.5
US
Eli Lilly and Co
NYSE:LLY
54.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
H
Humedix Co Ltd
KOSDAQ:200670
Average EV/EBITDA: 400.5
5.3
9%
0.6
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
109
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
H
Humedix Co Ltd
KOSDAQ:200670
Average EV/EBIT: 1 713
6.7
11%
0.6
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.5
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5